The organization advances prostate cancer research by supporting innovative scientific research, fostering strategic partnerships, and accelerating the development of breakthrough treatments.
Main program · fiscal year 2025
PCR supports innovative prostate cancer research focused on improving the classification of advanced prostate cancer, advancing personalized treatment approaches, and developing new therapies for advanced disease.$49,659 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 55¢ went to programs, 17¢ to management and 28¢ to fundraising.
Programs $49,659
Management $15,826
Fundraising $25,059
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
55%
Below
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$10,596Fiscal year 2025
Expenses$90,544Fiscal year 2025
Total assets$30,435Fiscal year 2025
Total liabilities$1,097,492Fiscal year 2025
Fiscal year ending December2025
Revenue$10,596
Expenses$90,544
Net income−$79,948
Net assets−$1,067,057
Notable sources of revenue
Percent of total revenue
Contributions
$10,596
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$30,435
Total liabilities
$1,097,492
Net assets
−$1,067,057
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$49,571
Expenses$309,574
Net income−$260,003
Net assets−$987,107
Notable sources of revenue
Percent of total revenue
Contributions
$49,571
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$44,344
Total liabilities
$1,031,451
Net assets
−$987,107
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$22,687
Expenses$420,739
Net income−$398,052
Net assets−$722,622
Notable sources of revenue
Percent of total revenue
Contributions
$22,687
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$30,551
Total liabilities
$753,173
Net assets
−$722,622
Compensation
Officers and key employees
$0
Share of expenses
0.0%
Fiscal year ending December2022
Revenue$0
Expenses$293,728
Net income−$293,728
Net assets−$324,984
Notable sources of revenue
Percent of total revenue
Contributions
$0
—
Program services
$0
—
Investment income
$0
—
Other (net)
$0
—
Assets / debt
Total assets
$29,232
Total liabilities
$354,216
Net assets
−$324,984
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?